ArticleBiosensors2026
From the Clinic, to the Clinic: Improving the Fluorescent Imaging Quality of ICG via Amphiphilic NIR-IIa AIE Probe.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering Nanoemulsions to Maximize NIR-II Fluorescence and Preserve Photothermal Performance of a Novel Boron Difluoride Formazanate Dye.Angewandte Chemie (International ed. in English) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Fluorescence imaging is crucial for providing detailed information in clinical practice. However, traditional first near-infrared (NIR-I) dyes such as indocyanine green (ICG) exhibit limitations such as shallow penetration depth, low contrast, and suboptimal clarity due to light scattering and autofluorescence. To overcome these drawbacks, we utilized a novel amphiphilic second near-infrared (NIR-II) aggregation-induced emission (AIE) probe (TCP) with an emission range beyond 1300 nm (NIR-IIa). Using approximately 200 co-registered NIR-I/NIR-IIa image pairs acquired with TCP, we trained a SwinUnet-based deep learning model to transform low-quality NIR-I ICG images into high-resolution NIR-IIa-like images. Owing to its superior brightness and photostability, TCP enhances in vivo fluorescent angiography, offering clearer vascular details and a higher signal-to-background ratio (SBR) in the NIR-IIa region, 2.6-fold higher than that of ICG in the NIR-I region. The deep learning model successfully converted blurred NIR-I images into high-SBR NIR-IIa-like images, achieving rapid imaging speeds without compromising quality. This work introduces a synergistic "probe-plus-AI" paradigm that substantially improves both the quality and speed of clinical fluorescence imaging, providing a pathway that is immediately translatable to enhanced diagnostics and image-guided surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.